EGFR and breast cancer: To better understand the potential relationship between the Erbb signaling pathway and miR-34a, Yilin Wang et al. used luciferase reporter gene analysis (Wang et al., 2017), and they discovered that overexpressing miR-34a decreased the expression of Erbb2 and prevented the invasion and growth of breast cancer cells in vitro.